A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive Glioblastoma
about
A Pilot Surgical Trial To Evaluate Early Immunologic Pharmacodynamic Parameters For The PD-1 Checkpoint Inhibitor, Pembrolizumab (MK-3475), In Patients With Surgically Accessible Recurrent/Progressive Glioblastoma
description
A clinical trial related to cancer immunotherapy, retrieved from clinicaltrials.gov
@en
klinisch onderzoek
@nl
name
A Pilot Surgical Trial To Eval ...... rrent/Progressive Glioblastoma
@en
A Pilot Surgical Trial To Eval ...... rrent/Progressive Glioblastoma
@nl
type
label
A Pilot Surgical Trial To Eval ...... rrent/Progressive Glioblastoma
@en
A Pilot Surgical Trial To Eval ...... rrent/Progressive Glioblastoma
@nl
prefLabel
A Pilot Surgical Trial To Eval ...... rrent/Progressive Glioblastoma
@en
A Pilot Surgical Trial To Eval ...... rrent/Progressive Glioblastoma
@nl
P6153
P1050
P3098
NCT02852655